Get started
HANARO MSCI VIROLOGYHANARO MSCI VIROLOGYHANARO MSCI VIROLOGY

HANARO MSCI VIROLOGY

No trades
See on Supercharts
Overview
Analysis
Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪1.75 B‬ KRW
Fund flows (1Y)
‪−2.78 B‬ KRW
Dividend yield (indicated)
1.24%
Discount/Premium to NAV
0.06%
Shares outstanding
‪150.00 K‬
Expense ratio
0.50%

About HANARO MSCI VIROLOGY


Issuer
HANWHA LIFE INSURANCE Co., Ltd.
Brand
Amundi
Home page
nh-amundi.com
Inception date
Jun 8, 2022
Index tracked
MSCI World IMI Virology Select Index - KRW - Benchmark TR Net
Replication method
Physical
Management style
Passive
Primary advisor
NH-Amundi Asset Management Co., Ltd.
ISIN
KR7432850006

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Vanilla
Geography
Developed Markets
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of February 20, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Cash
Stocks74.48%
Health Technology74.48%
Bonds, Cash & Other25.52%
Cash25.52%
Stock breakdown by region
71%28%
North America71.84%
Europe28.16%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows